1 | AD-MSC transdifferentiated HSCs (AD-HSCs) | - | - | - | - | [1] 60 60 |
2 | Adipose derived mesenchymal stem cells ( AD-MSCs) | - | - | - | - | [1] 60 60 |
3 | Adipose-cord mesenchymal stromal cells (A-MSCs) | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 97 97 |
4 | Allogeneic adipose tissue-derived MSC | - | - | - | - | [1] 36 36 |
5 | Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 |
6 | Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 |
7 | Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 |
8 | Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg) | - | - | - | - | [1] 6 6 |
9 | Allogeneic MSC (AlloMSC) | - | - | - | - | [1] 49 49 |
10 | Autologous Adipose Derived MSCs (ADMSCs) | - | - | - | - | [1] 85 85 |
11 | Autologous Mesenchymal stem cells (MSCs) | - | - | - | - | [1] 2 2 |
12 | Autologous MSC-NTF cells | - | - | - | - | [1] 2 2 |
13 | Bone Marrow Derived Mesenchymal Stem cells (MSCs) | - | - | - | - | [1] 96 96 |
14 | Bone Marrow MSC Derived Extracellular Vesicle Isolate | - | - | - | - | [1] 96 96 |
15 | High Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 |
16 | HUC-MSC + DMARDs | - | - | - | - | [1] 46 46 |
17 | HUC-MSC infusion (BC-U001) | - | - | - | - | [1] 46 46 |
18 | HUC-MSC suspension | - | - | - | - | [1] 46 46 |
19 | Human Allogeneic WJ-MSCs | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 36 36 |
20 | Human umbilical cord derived MSC transplantation for SLE | - | - | - | - | [1] 49 49 |
21 | Human umbilical cord mesenchymal stem cells (UC-MSCs) | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 96 96 |
22 | Human umbilical cord-derived MSCs | - | - | - | - | [1] 271 271 |
23 | Injection of Umbilical cord derived MSCs | - | - | - | - | [1] 6 6 |
24 | Intrathecal administration of autologous MSC-NP | - | - | - | - | [1] 13 13 |
25 | Intrathecal MSC-NP injection | - | - | - | - | [1] 13 13 |
26 | Intravenous administration of 1 million of MSC | - | - | - | - | [1] 2 2 |
27 | Intravenous administration of 2 million of MSC | - | - | - | - | [1] 2 2 |
28 | Intravenous administration of 4 million of MSC | - | - | - | - | [1] 2 2 |
29 | Intravenous infusion of MSCs | - | - | - | - | [1] 271 271 |
30 | Low Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 |
31 | Mesenchymal stem cells (MSC) | - | - | - | - | [3] 2 2, 13, 96 |
32 | Mesenchymal stem cells (MSCs) | - | - | - | - | [3] 13 13, 36, 96 |
33 | Mesenchymal stem cells derived from bone marrow (BM-MSCs) | - | - | - | - | [1] 36 36 |
34 | Mesenchymal stromal cells (MSC) for infusion | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 96 96 |
35 | MSC | - | - | - | - | [6] 6 6, 51, 60, 96, 97, 271 |
36 | MSC injection 01 | - | - | - | - | [1] 96 96 |
37 | MSC injection 02 | - | - | - | - | [1] 96 96 |
38 | MSC treatment | - | - | - | - | [1] 49 49 |
39 | MSC treatment 01 | - | - | - | - | [1] 96 96 |
40 | MSC treatment 02 | - | - | - | - | [1] 96 96 |
41 | MSC+ATG | - | - | - | - | [1] 60 60 |
42 | MSC-AFP | - | - | - | - | [1] 96 96 |
43 | MSC-NTF cells transplantation (IM) | - | - | - | - | [1] 2 2 |
44 | MSC-NTF cells transplantation (IT) | - | - | - | - | [1] 2 2 |
45 | MSC2015 | - | - | - | - | [1] 13 13 |
46 | MSC2304479A | - | - | - | - | [1] 13 13 |
47 | MSC2304480A | - | - | - | - | [1] 13 13 |
48 | MSC2304481A | - | - | - | - | [1] 13 13 |
49 | MSC2304482A | - | - | - | - | [1] 13 13 |
50 | MSC2358825A | - | - | - | - | [1] 13 13 |
51 | MSC2364447C | - | - | - | - | [2] 13 13, 49 |
52 | MSC2430913A or ONO-4641 (to be used as synonyms) | - | - | - | - | [1] 13 13 |
53 | MSC2491529A | - | - | - | - | [1] 13 13 |
54 | MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF | - | - | - | - | [1] 2 2 |
55 | MSCs | - | - | - | - | [1] 228 228 |
56 | NurOwn (MSC-NTF cells) | - | - | - | - | [1] 13 13 |
57 | NurOwn® (MSC-NTF cells) | - | - | - | - | [1] 2 2 |
58 | NW-1015E, EMD 1195686, MSC2191632B | - | - | - | - | [1] 6 6 |
59 | Only 1 arm: treatment with MSC-AFP | - | - | - | - | [1] 96 96 |
60 | ONO-4641/ MSC2430913A | - | - | - | - | [1] 13 13 |
61 | ONO-4641/MSC2430913A | - | - | - | - | [1] 13 13 |
62 | Ossium vBM-MSC | - | - | - | - | [1] 96 96 |
63 | Other: Human umbilical cord-derived MSCs and cyclosporin A | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
64 | Other: MSCs | - | - | - | - | [1] 13 13 |
65 | Other: UC-MSCs by peripheral intravenous infusion | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 96 96 |
66 | Suspension of human autologous MSC 3P in 1,5 ml | - | - | - | - | [1] 2 2 |
67 | Suspension of human autologous MSC 3P in 1.5 ml | - | - | - | - | [1] 2 2 |
68 | TC-MSC | - | - | - | - | [2] 36 36, 107 |
69 | UC-MSC+DMARDS | - | - | - | - | [1] 46 46 |
70 | UC-MSCs | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [2] 46 46, 96 |
71 | Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation | - | - | - | - | [2] 93 93, 296 |
72 | Umbilical Cord Mesenchymal Stem Cell (UC-MSC) | - | - | - | - | [1] 90 90 |
73 | Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 46 46 |
74 | WJ-MSCs | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells (Synonym: WJ-MSCs) | - | - | - | [1] 36 36 |